AN2 Therapeutics (ANTX) Gets Gates Funding Extension for TB Program
AN2 Therapeutics said the Gates Foundation extended funding to support its ongoing TB research collaboration with GSK on boron-based LeuRS inhibitors.Material DetailsContext by AI AnalystThis is an early-stage R&D funding and partnership update that supports AN2’s infectious disease platform narrat…